Ma CJ - Search Results

1

Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting.

Ma CJ, Huang CW, Chang TK, Tsai HL, Su WC, Yeh YS, Chen PJ, Wang JY. Ma CJ, et al. Transl Oncol. 2019 Mar;12(3):502-512. doi: 10.1016/j.tranon.2018.12.003. Epub 2018 Dec 27. Transl Oncol. 2019. PMID: 30594039 Free PMC article.

2

FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping.

Lu CY, Yeh YS, Huang CW, Ma CJ, Yu FJ, Wang JY. Lu CY, et al. Among authors: ma cj. Onco Targets Ther. 2014 Nov 21;7:2143-6. doi: 10.2147/OTT.S69774. eCollection 2014. Onco Targets Ther. 2014. PMID: 25473295 Free PMC article.

3

Clinical Implication of UGT1A1 Promoter Polymorphism for Irinotecan Dose Escalation in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Combined with FOLFIRI in the First-line Setting.

Lu CY, Huang CW, Wu IC, Tsai HL, Ma CJ, Yeh YS, Chang SF, Huang ML, Wang JY. Lu CY, et al. Among authors: ma cj. Transl Oncol. 2015 Dec;8(6):474-9. doi: 10.1016/j.tranon.2015.11.002. Transl Oncol. 2015. PMID: 26692528 Free PMC article.

4

Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment.

Huang CW, Yeh YS, Ma CJ, Tsai HL, Chen CW, Huang MY, Lu CY, Wu JY, Wang JY. Huang CW, et al. Among authors: ma cj. Chemotherapy. 2017;62(1):80-84. doi: 10.1159/000447118. Epub 2016 Sep 22. Chemotherapy. 2017. PMID: 27654129

5

Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.

Tsai HL, Chen YT, Yeh YS, Huang CW, Ma CJ, Wang JY. Tsai HL, et al. Among authors: ma cj. Pathol Oncol Res. 2019 Jul;25(3):905-913. doi: 10.1007/s12253-017-0381-5. Epub 2018 Jan 3. Pathol Oncol Res. 2019. PMID: 29299827 Free article.

6

Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes-A Nationwide Cohort Study.

Chang YT, Tsai HL, Kung YT, Yeh YS, Huang CW, Ma CJ, Chiu HC, Wang JY. Chang YT, et al. Among authors: ma cj. Transl Oncol. 2018 Apr;11(2):535-541. doi: 10.1016/j.tranon.2018.02.012. Epub 2018 Mar 7. Transl Oncol. 2018. PMID: 29524831 Free PMC article.

7

Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial.

Ma CJ, Chang TK, Tsai HL, Su WC, Huang CW, Yeh YS, Chang YT, Wang JY. Ma CJ, et al. Trials. 2019 Dec 19;20(1):751. doi: 10.1186/s13063-019-3917-z. Trials. 2019. PMID: 31856912 Free PMC article.

8

Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy.

Huang CM, Huang CW, Ma CJ, Yeh YS, Su WC, Chang TK, Tsai HL, Juo SH, Huang MY, Wang JY. Huang CM, et al. Among authors: ma cj. J Oncol. 2020 Jan 28;2020:9437684. doi: 10.1155/2020/9437684. eCollection 2020. J Oncol. 2020. PMID: 32411245 Free PMC article.

9

Effect of KRAS and NRAS mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases.

Chuang SC, Huang CW, Chen YT, Ma CJ, Tsai HL, Chang TK, Su WC, Hsu WH, Kuo CH, Wang JY. Chuang SC, et al. Among authors: ma cj. Oncol Lett. 2020 Sep;20(3):2119-2130. doi: 10.3892/ol.2020.11795. Epub 2020 Jul 1. Oncol Lett. 2020. PMID: 32782529 Free PMC article.

10

Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer.

Yeh YS, Huang MY, Ma CJ, Huang CW, Tsai HL, Chen YC, Li CC, Yu FJ, Shih HY, Wang JY. Yeh YS, et al. Among authors: ma cj. J Oncol. 2020 Sep 7;2020:6931317. doi: 10.1155/2020/6931317. eCollection 2020. J Oncol. 2020. PMID: 32963531 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters